key: cord-0715759-fcljvz9e
authors: Likhvantsev, V.; Landoni, G.; Perekhodov, S.; Chaus, N.; Kadantseva, K.; Ermokhina, L.; Baeva, A.; Yadgarov, M.; Berikashvili, L.; Kuzovlev, A.; Grechko, A.
title: Six-Month Quality of Life in COVID-19 Intensive Care Unit Survivors
date: 2021-08-28
journal: J Cardiothorac Vasc Anesth
DOI: 10.1053/j.jvca.2021.08.036
sha: 16aecb10235e35745b431262ebbfcef5925f353e
doc_id: 715759
cord_uid: fcljvz9e

OBJECTIVE(S): : Since there is increasing evidence of serious deterioration in long-term Quality of Life (QoL) in COVID-19 intensive care unit (ICU) survivors, we identified predictors of poor quality of life in these patients. DESIGN: : Prospective cohort study. SETTING: : Research hospital repurposed in to a COVID-19 center. PARTICIPANTS: : Consecutive patients admitted in COVID-19 ICU between March and June 2020. INTERVENTIONS: : A SF-36 questionnaire, which includes physical and mental items, was used 6 months after patients discharge. MEASUREMENTS AND MAIN RESULTS: : 403 patients were managed in the ICU with a hospital mortality of 181/403 (44.9%) while 16 (4.0%) further patients died within 6 months. Among the 125 questionnaire responders, only 32.0% and 52% had a normal quality of life in terms of the physical and mental component of health. Multivariable analysis identified low-molecular-weight heparin treatment in ICU as the only modifiable factor associated with an increase in physical component of QoL OR: 3.341 (95%CI 1.298-8.599), p=0.012, while age ≥52 years OR 0.223 and female sex OR 0.321 were significantly associated with a decrease in the physical component. Medical history of cerebrovascular insufficiency was significantly associated with a decrease in mental component of QoL OR: 0.125, while the only factor associated with an increase in the mental health component was BMI ≥ 27.6 kg / m2 OR 7.466. CONCLUSIONS: : In COVID-19 intensive care unit survivors we identified treatment with low molecular weight heparin as a predictor of improved physical component of QoL at 6-months.

Long-term consequences of COVID-19 are still seldom reported [1] [2] [3] [4] [5] [6] and include fatigue and muscle weakness [3, 6] , dyspnea with minimal exertion [4, 5] , sleep disturbance, anxi-ety and depression [1] . Sonnweber T et al. reported that 100 days after discharge a relevant percentage of COVID-19 patients had persisting symptoms and lung function impairment along with pulmonary abnormalities [7] . Therefore, emerging evidence suggests a persistent and serious deterioration in Quality of Life (QoL) of COVID-19 survivors and this represents a serious medical and social problem.

Long term full recovery after ICU discharge has been an issue of great interest for intensive care specialists in the last decade: causes, diagnoses and treatment of post intensive care syndrome (PICS) have been widely discussed. [8] . PICS describes a variety of health disorders occurring often among patients who survive critical illness and intensive care [9] . It is generally accepted that patients with PICS require long-term medical and social rehabilitation [10] . PICS patients showed a significantly worse QoL along with higher risk of sudden death compared to general population [11] . However, there is still few data regarding the features of PICS in COVID-19 survivors. Furthermore, predictors of QoL are poorly investigated.

In this study, we present a large case series of COVID-19 ICU survivors. Our aim was to assess QoL of these patients at a 6-month follow up. Furthermore, we tried to identify modifiable risk factors and outcome predictors.

Consecutive COVID-19 patients admitted in the ICUs of a single center between March and June 2020 were enrolled with approval Ethics Committee (№ 2/21/1 on 02. 16.2021 ). All patients signed a written consent before answering to the questionnaire. Exclusion criteria were: cardiac arrest before or at the moment of ICU admission (n=13); transferred to another hospital irrespectively of the reason (n=88); preliminary diagnosis of COVID-19 not confirmed after additional examination (n=66).

The primary endpoint of the study was QoL 6 months after hospital discharge. We estimated QoL through the SF-36 questionnaire, which includes items about physical and mental health.

Criteria for ICU admission are specified in the Supplement (supplemental Table 1 ).

Treatment in ICU is detailed in the Supplement (supplemental table 2 ). Prescription of LMWH or UFH was made at discretion of the attending physician. Collected data (supplemental Table 3) consisted of demographic characteristics (age, sex, BMI), comorbidities according to Charlson comorbidity index [12] and detailed in the Supplement, PaO2/FiO2 levels and laboratory parameters at time of ICU admission, patient's condition at admission (national early warning score [13] ) and SOFA score. Also, days on ventilator, days in ICU and hospital stay were considered.

Computed tomography was evaluated by the same team of radiologists using the same criteria: each of the five lung lobes was visually scored for the degree of lung involvements using a point-scale: no involvement; 1-25% involvement; 26% -49% involvement; 50% -75% involvement; 76% -100% involvement.

The 6 months follow up period started at hospital discharge. Experienced staff did up to three attempts to contact the patients through the phone. If the patient agreed to fill in the survey (available in the Supplement) the login and password to the unique record of the questionnaire was sent to the participant. Moreover, we attached the consent form by the email, asking kindly to fill it in and send it back.

The analysis of QoL was carried out through SF-36 Health Status Survey. SF-36 refers to nonspecific questionnaires designed to measure health and QoL at the individual level in clinical practice and is widely used in the United States and European countries. It is composed of 11 questions and 36 items which cover eight domains of health (Supplemental material). Health domains (multiple-item subscales) evaluate physical function (limitations in physical activities because of health problems), social functioning (limitations in social activities because of physical or emotional problems), role limitations due to physical problems, role limitations due to emotional problems, mental health, bodily pain, vitality (energy and fatigue) and general health perception (psychological distress and well-being). The overall score on each SF-36 subscale ranges from 0 to 100, and a higher score indicates a better Quality of Life. Scores for the different subscales were converted and pooled using a scoring key (Z-scores) and then two total measurements were calculated by combining the subscale scores -physical and mental components of QoL [14] . A reference level of 50 points was adopted for physical and mental health components, as calculated for the US population [15] and validated in Australia, France and Italy. SF-36 uses norm-based scoring algorithms for all eight subscales (T-score transformation with mean, 50±10 [SD]). Subsequently, patients were divided into two groups based on physical and mental components: 1) less than 50 points (decreased QoL); 2) 50 or more points (normal QoL).

The Shapiro-Wilk test was used to assess the normality of data. Descriptive statistics were used to describe the sample; continuous variables were described using mean and standard deviation (SD). For non-normal distributions, such as medians and interquartile ranges, categorical variables were described using frequency and percentages.

Group differences (normal versus reduced QoL) were explored using Mann Whitney U test for continuous variables (with the values of the statistics of the criterion U and Z). Categorical variables were analyzed using Fisher's exact test. The Spearman rank correlation coefficient was used as a hypothesis test to study the relationship between variables. The risk of outcome in univariate analysis was assessed using the OR (odds ratio) and its 95% confidence interval for each predictor studied. In multivariable analysis, adjusted OR was calculated using binary logistic regression in order to take into account the influence of confounders (e.g. age, gender, comorbidity, and ongoing therapy). Predictors were included in the regression model based on the forward stepwise (Wald) method. To assess the quality of various quantitative indicators as predictors of QoL, we used the ROC analysis with the assessment of AUC parameter and its 95% confidence interval (CI). The cut-off value was chosen in order to achieve the optimal sensitivity / specificity ratio according to the results of the ROC analysis (Youden's J statistic).

All analyses were carried out using SPSS® Software version 25 and MedCalc® Statistical Software version 19.5.6. The significance level was set at 0.05. Comorbidities, patient characteristics, prescribed therapy, and their association with 6month QoL are showed in Table 1 and Table 2 . Patients were comparable in terms of lung involvement at computed tomography and hospital stay before transfer to the ICU (Table 2) ; frequency of antibiotic prescription, PaO2/FiO2 levels and laboratory parameters at the time of admission to the ICU did not differ significantly in patients with normal and decreased QoL (supplemental Table 3 ). in previous studies [18, 19] including a recent study on 6-months Qol that was performed with SF-36 scale in patients with COVID-19 [20] . We set the age cut-off at >52 years, which is significantly lower than the one usually found in literature (>65) [21, 22] , this can be attributed to the specific SARS-CoV-2 virus characteristics and to the impact of environmental factors in different countries [23] . The surprising findings of female sex being a predictor of poor outcome in terms of the physical component of QoL might be, at least in part, a consequence of the drawbacks of the SF-36 scale itself. Some aspects related to physical activity are a priori easier to perform for men than for women, and this could lead to an underestimation of the physical component of QoL in females. Furthermore, previous studies which identified female sex as a predictor of positive outcomes [24, 25] considered short term outcomes and not 6-months follow up. Further studies are required to clarify and confirm this important issue. Furthermore, treatment with LMWH in ICU was an independent and modifiable predictor of improvement in physical component of QoL 6 months after hospital discharge. This is in line with existing evidence that severe SARS-Cov-2 pneumonia is a consequence of systemic inflammatory response and microvascular pulmonary thrombosis. Therefore, anticoagulant therapy confirms to be an essential and mandatory component of COVID-19 treatment [26] [27] [28] . Surprisingly, we failed to confirm a similar beneficial effect for unfractionated heparin. This might be explained by the pleiotropic pharmacological effects of LMWH [29] or by the use of a relatively low dose unfractionated heparin. Our findings are in agreement with Sholzberg M et al., who recently found a better survival associated with high dose heparin in moderately ill patients with COVID-19 [30] . Furthermore, even if we used a multivariable model to minimize the effect of confounders, we cannot exclude that the small sample size and the severity of the patient's condition at admission (SOFA, NEWS scores, as well as gender, age, and comorbidity) confounded the findings (eg prescription of unfractionated heparin to the most severe patients). This could also be explained by a selection bias induced by the clinician who might be more tempted to use LMWH in patient who do well compared to other who might need invasive procedure for example due to their worse clinical status. All other medications, such as tocilizumab, hydroxychloroquine and antivirals (lopinavir-ritonavir and oseltamivir) showed no benefits in terms of physical component of QoL in our cohort.

In contrast with reported evidence linking obesity with poor mental QoL outcomes in COVID-19 survivors, our data suggests that a BMI ≥ 27.6 kg/m2 might be a predictor of good outcome in mental component of QoL: adj. OR 7.466 (95%CI: 1.950-28.582), p=0.007 [31] . Even if counterintuitive, our findings are not in contrast with previous literature on the relationship between the mental component of QoL and BMI. Chen KY et al. [32] ) found that obesity in COVID-19 patients was an independent predictor of a decline in the physical component of health, but not the mental one. Hańczewski M et al. [33] found that after laparoscopic appendectomy the mental component of QoL was 72.0 versus 79.5 in patients with BMI ≤ 25 versus >25. Unsurprisingly, we confirmed that cerebrovascular insufficiency was significantly associated with a decrease in mental component of QoL [34] . Steffens DC et al. already described an association between depressive symptoms and cerebrovascular disease in elderly general population [35] .

Our study has strengths and limitations. It is a single center study with several patients lost to follow up and therefore its external validity is limited. The sickest patients, many with serious comorbidities, would have succumbed given the relatively high mortality rate of the study cohort. Therefore, even though comorbidities did not surface as independent negative predictors, they certainly can't be ignored. We also acknowledge that we did not register this (nonrandomized) study in an international registry. Moreover, we failed to collect and include in the model several in-hospital clinically relevant data and treatments. Finally, we did not investigate if young patients were able to return to their "before-covid19" job. We were not able to describe the causes of death after hospital discharge and we did not assess all possible domains of QoL (eg memory loss). At the same time the studied population is relatively large and only a few midterm outcome studies including QoL questionnaire have been performed so far in COVID-19

survivors. Moreover, decrease in QoL in COVID-19 ICU survivors is a topic of great interest because it represents a social and medical problem and modifiable risk factors and predictors are not known so far. Therefore, we also underline the originality of our findings.

Only 32% of Russian ICU survivors did not report serious problems with physical component health 6 months after discharge, and 52% had no problems related to the mental component. LMWH treatment in ICU was the only modifiable predictor in physical component in critically ill patients with COVID-19 6 months after discharge. Age over 52 years and female gender were independent risk factors for worse physical outcomes. None of the investigated drugs had an impact on the 6 months mental outcomes. BMI ≤ 27.6 kg / m2 and cerebrovascular impairment at admission were independent risk factors for adverse outcome in terms of mental component of QoL. 

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Persistent symptoms in patients after acute COVID-19

Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase

Chest CT and clinical follow-up of discharged patients with COVID-19 in Wenzhou City

Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery

Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study

Cardiopulmonary recovery after COVID-19 -an observational prospective multi-center trial

Long-term outcomes after critical illness: recent insights

Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference

Impact of critical illness on resource utilization: A comparison of use in the year before and after ICU admission

Quality of life in the five years after intensive care: a cohort study

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Royal College of Physicians. National early warning score (NEWS): standardising the assessment of acute-illness severity in the NHS

SF-36 total score as a single measure of health-related quality of life: Scoping review

SF-36 health survey update. Spine (Phila Pa

Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial

Enhancing Recovery From Sepsis

Age, frailty, and comorbidity as prognostic factors for short-term outcomes in patients with coronavirus disease 2019 in geriatric care

Factors associated with COVID-19-related death using OpenSAFELY

Health-related quality of life of COVID-19 survivors at 6 months after hospital discharge: a cohort study

Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection

Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry

Why are Asian countries outperforming the Western world in controlling COVID-19 pandemic? Pathog Glob Health

Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19)-a Danish nationwide, register-based study

Short-term outcomes of COVID-19 and risk factors for progression

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

COVID-19-Related Thromboinflammatory Status: MicroCLOTS and Beyond (Editorial)

COVID-19 mortality in patients on anticoagulants and antiplatelet agents

Anticoagulant activity and pleiotropic effects of heparin

Heparin for Moderately Ill Patients with Covid-19. medRxiv

The same storm but not the same boat: Effects of COVID-19 stay-at-home order on mental health in individuals with overweight

Predictors of Health-Related Quality of Life and Influencing Factors for COVID-19 Patients, a Follow-Up at One Month. Front Psychiatry

Effect of BMI on the quality of life in patients after appendectomy depending on surgical modality

The cerebral circulation and cerebrovascular disease II: Pathogenesis of cerebrovascular disease

Cerebrovascular disease and depression symptoms in the cardiovascular health study